The latest price target for Ardent Health Partners (NYSE:ARDT) was reported by B of A Securities on August 12, 2024. The analyst firm set a price target for $22.00 expecting ARDT to rise to within 12 months (a possible 36.39% upside). 9 analyst firms have reported ratings in the last year.

The latest analyst rating for Ardent Health Partners (NYSE:ARDT) was provided by B of A Securities, and Ardent Health Partners initiated their buy rating.

There is no last upgrade for Ardent Health Partners

There is no last downgrade for Ardent Health Partners.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ardent Health Partners, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ardent Health Partners was filed on August 12, 2024 so you should expect the next rating to be made available sometime around August 12, 2025.

While ratings are subjective and will change, the latest Ardent Health Partners (ARDT) rating was a initiated with a price target of $0.00 to $22.00. The current price Ardent Health Partners (ARDT) is trading at is $16.13, which is within the analyst’s predicted range.